Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

The fracture point in AI adoption: Why middle managers are drowning under corporate ambition

27/06/2026 Published by Pharma Biz

The divide between strategic vision and operational reality Global workforce analytics show that while approximately 88% of organizations have integrated... Read more

Tags: #Capability Development

Dominating the Pediatric Immunology Market: Analyzing AbbVie’s Strategic FDA Label Expansion for SKYRIZI®

27/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical powerhouse AbbVie (NYSE: ABBV) has officially secured U.S. Food and Drug Administration (FDA) approval expanding the... Read more

Category: Uncategorized

Tags: #Global Trends

Commercializing Neuraminidase Inhibitor Generics: Analyzing Alembic’s USFDA Approval for Tamiflu Oral Suspension

27/06/2026 Published by Pharma Biz

Key Development Indian pharmaceutical manufacturer Alembic Pharmaceuticals Ltd has secured final regulatory approval from the US Food and Drug Administration... Read more

Category: Uncategorized

Tags: #Global Trends

Consolidating Oncological Diagnostics: Analyzing Agilent’s $950 Million Acquisition of Biocare Medical

27/06/2026 Published by Pharma Biz

Key Development Global life sciences and diagnostics titan Agilent Technologies Inc. has officially finalized its previously announced acquisition of Biocare... Read more

Category: Uncategorized

Tags: #M&A

AI-Driven Target Discovery: Analyzing Boehringer Ingelheim’s Strategic T-Cell Alliance with Immunai

27/06/2026 Published by Pharma Biz

Key Development German pharmaceutical major Boehringer Ingelheim has finalized a comprehensive multi-project research collaboration with biotech innovator Immunai to identify... Read more

Category: Uncategorized

Tags: #Global Trends

Realigning the Life Sciences Architecture: Analyzing Merck KGaA’s $11.3 Billion Bio-Techne Takeover

27/06/2026 Published by Pharma Biz

Key Development German healthcare and electronics conglomerate Merck KGaA has finalized a definitive, blockbuster agreement to acquire Bio-Techne Corporation in... Read more

Category: Uncategorized

Tags: #M&A

Shifting Paradigms in VMS Valuations: Haleon Bids for Thorne as Private Equity Eyes a $4 Billion Exit

27/06/2026 Published by Pharma Biz

Key Development The global consumer health landscape witnessed a major strategic consolidation play as Haleon, the multi-billion-dollar manufacturer of Centrum... Read more

Category: Uncategorized

Tags: #Global Trends

Reversing Corporate Crisis: US Supreme Court’s Roundup Ruling Delivers Victory to Bayer, Reshaping Life Sciences Risk Frameworks

27/06/2026 Published by Pharma Biz

Key Development The U.S. Supreme Court has delivered a landmark legal victory to German life sciences conglomerate Bayer, issuing a... Read more

Category: Uncategorized

Tags: #Global Trends

Reshaping Hematological Oncology landscapes: Analyzing CHMP’s Positive Opinion for Eli Lilly’s Jaypirca

27/06/2026 Published by Pharma Biz

Key Development The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 68 Page 69 Page 70 … Page 227 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members